Injectable Sumatriptan Market Insights, Global Outlook and Forecast 2022-2028
Injectable Sumatriptan Market Insights, Global Outlook and Forecast 2022-2028
Insights into the Injectable Sumatriptan Market include supply chain optimization, Injectable Sumatriptan challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Sumatriptan injection comes as a solution (liquid) to inject subcutaneously (just under your skin). It is usually used at the first sign of a migraine headache. If your symptoms improve after you use sumatriptan but return after 1 hour or longer, you may use a second dose of sumatriptan.
The latest research study released by Market IntelliX evaluates market size and forecasts of Injectable Sumatriptan in global, including the following market information:
Global Injectable Sumatriptan Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Injectable Sumatriptan Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Injectable Sumatriptan companies in 2021 (%)
The global Injectable Sumatriptan market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
4mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Sumatriptan include GlaxoSmithKline, Pfizer, Teva and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Injectable Sumatriptan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Injectable Sumatriptan Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, by Type, 2021 (%)
4mg
6mg
Others
Global Injectable Sumatriptan Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Injectable Sumatriptan Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Sumatriptan revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Injectable Sumatriptan revenues share in global market, 2021 (%)
Key companies Injectable Sumatriptan sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Injectable Sumatriptan sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
GlaxoSmithKline
Pfizer
Teva
Sun Pharma
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Injectable Sumatriptan Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Sumatriptan Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injectable Sumatriptan Overall Market Size
2.1 Global Injectable Sumatriptan Market Size: 2021 VS 2028
2.2 Global Injectable Sumatriptan Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Injectable Sumatriptan Sales: 2017-2028
3 Company Landscape
3.1 Top Injectable Sumatriptan Players in Global Market
3.2 Top Global Injectable Sumatriptan Companies Ranked by Revenue
3.3 Global Injectable Sumatriptan Revenue by Companies
3.4 Global Injectable Sumatriptan Sales by Companies
3.5 Global Injectable Sumatriptan Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Injectable Sumatriptan Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Injectable Sumatriptan Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injectable Sumatriptan Players in Global Market
3.8.1 List of Global Tier 1 Injectable Sumatriptan Companies
3.8.2 List of Global Tier 2 and Tier 3 Injectable Sumatriptan Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Injectable Sumatriptan Market Size Markets, 2021 & 2028
4.1.2 4mg
4.1.3 6mg
4.1.4 Others
4.2 By Type - Global Injectable Sumatriptan Revenue & Forecasts
4.2.1 By Type - Global Injectable Sumatriptan Revenue, 2017-2022
4.2.2 By Type - Global Injectable Sumatriptan Revenue, 2023-2028
4.2.3 By Type - Global Injectable Sumatriptan Revenue Market Share, 2017-2028
4.3 By Type - Global Injectable Sumatriptan Sales & Forecasts
4.3.1 By Type - Global Injectable Sumatriptan Sales, 2017-2022
4.3.2 By Type - Global Injectable Sumatriptan Sales, 2023-2028
4.3.3 By Type - Global Injectable Sumatriptan Sales Market Share, 2017-2028
4.4 By Type - Global Injectable Sumatriptan Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Injectable Sumatriptan Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Injectable Sumatriptan Revenue & Forecasts
5.2.1 By Application - Global Injectable Sumatriptan Revenue, 2017-2022
5.2.2 By Application - Global Injectable Sumatriptan Revenue, 2023-2028
5.2.3 By Application - Global Injectable Sumatriptan Revenue Market Share, 2017-2028
5.3 By Application - Global Injectable Sumatriptan Sales & Forecasts
5.3.1 By Application - Global Injectable Sumatriptan Sales, 2017-2022
5.3.2 By Application - Global Injectable Sumatriptan Sales, 2023-2028
5.3.3 By Application - Global Injectable Sumatriptan Sales Market Share, 2017-2028
5.4 By Application - Global Injectable Sumatriptan Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Injectable Sumatriptan Market Size, 2021 & 2028
6.2 By Region - Global Injectable Sumatriptan Revenue & Forecasts
6.2.1 By Region - Global Injectable Sumatriptan Revenue, 2017-2022
6.2.2 By Region - Global Injectable Sumatriptan Revenue, 2023-2028
6.2.3 By Region - Global Injectable Sumatriptan Revenue Market Share, 2017-2028
6.3 By Region - Global Injectable Sumatriptan Sales & Forecasts
6.3.1 By Region - Global Injectable Sumatriptan Sales, 2017-2022
6.3.2 By Region - Global Injectable Sumatriptan Sales, 2023-2028
6.3.3 By Region - Global Injectable Sumatriptan Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Injectable Sumatriptan Revenue, 2017-2028
6.4.2 By Country - North America Injectable Sumatriptan Sales, 2017-2028
6.4.3 US Injectable Sumatriptan Market Size, 2017-2028
6.4.4 Canada Injectable Sumatriptan Market Size, 2017-2028
6.4.5 Mexico Injectable Sumatriptan Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Injectable Sumatriptan Revenue, 2017-2028
6.5.2 By Country - Europe Injectable Sumatriptan Sales, 2017-2028
6.5.3 Germany Injectable Sumatriptan Market Size, 2017-2028
6.5.4 France Injectable Sumatriptan Market Size, 2017-2028
6.5.5 U.K. Injectable Sumatriptan Market Size, 2017-2028
6.5.6 Italy Injectable Sumatriptan Market Size, 2017-2028
6.5.7 Russia Injectable Sumatriptan Market Size, 2017-2028
6.5.8 Nordic Countries Injectable Sumatriptan Market Size, 2017-2028
6.5.9 Benelux Injectable Sumatriptan Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Injectable Sumatriptan Revenue, 2017-2028
6.6.2 By Region - Asia Injectable Sumatriptan Sales, 2017-2028
6.6.3 China Injectable Sumatriptan Market Size, 2017-2028
6.6.4 Japan Injectable Sumatriptan Market Size, 2017-2028
6.6.5 South Korea Injectable Sumatriptan Market Size, 2017-2028
6.6.6 Southeast Asia Injectable Sumatriptan Market Size, 2017-2028
6.6.7 India Injectable Sumatriptan Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Injectable Sumatriptan Revenue, 2017-2028
6.7.2 By Country - South America Injectable Sumatriptan Sales, 2017-2028
6.7.3 Brazil Injectable Sumatriptan Market Size, 2017-2028
6.7.4 Argentina Injectable Sumatriptan Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Injectable Sumatriptan Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Injectable Sumatriptan Sales, 2017-2028
6.8.3 Turkey Injectable Sumatriptan Market Size, 2017-2028
6.8.4 Israel Injectable Sumatriptan Market Size, 2017-2028
6.8.5 Saudi Arabia Injectable Sumatriptan Market Size, 2017-2028
6.8.6 UAE Injectable Sumatriptan Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Injectable Sumatriptan Major Product Offerings
7.1.4 GlaxoSmithKline Injectable Sumatriptan Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Injectable Sumatriptan Major Product Offerings
7.2.4 Pfizer Injectable Sumatriptan Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Teva
7.3.1 Teva Corporate Summary
7.3.2 Teva Business Overview
7.3.3 Teva Injectable Sumatriptan Major Product Offerings
7.3.4 Teva Injectable Sumatriptan Sales and Revenue in Global (2017-2022)
7.3.5 Teva Key News
7.4 Sun Pharma
7.4.1 Sun Pharma Corporate Summary
7.4.2 Sun Pharma Business Overview
7.4.3 Sun Pharma Injectable Sumatriptan Major Product Offerings
7.4.4 Sun Pharma Injectable Sumatriptan Sales and Revenue in Global (2017-2022)
7.4.5 Sun Pharma Key News
8 Global Injectable Sumatriptan Production Capacity, Analysis
8.1 Global Injectable Sumatriptan Production Capacity, 2017-2028
8.2 Injectable Sumatriptan Production Capacity of Key Manufacturers in Global Market
8.3 Global Injectable Sumatriptan Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Injectable Sumatriptan Supply Chain Analysis
10.1 Injectable Sumatriptan Industry Value Chain
10.2 Injectable Sumatriptan Upstream Market
10.3 Injectable Sumatriptan Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Injectable Sumatriptan Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Injectable Sumatriptan Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|